Apr 30, 2026 07:00AM
Apr 13, 2026 07:01AM
Apr 13, 2026 07:00AM
Feb 26, 2026 07:00AM
Jan 13, 2026 07:01AM
Jan 13, 2026 07:00AM
Dec 11, 2025 07:02AM Kymera gets FDA Fast Track status for atopic dermatitis drug KT-621
Dec 11, 2025 07:00AM
Nov 16, 2025 03:00PM
Oct 31, 2024 07:30AM
Oct 9, 2024 07:01AM
Oct 9, 2024 07:00AM
Jun 20, 2024 08:45AM
Jan 17, 2024 08:00AM INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
Nov 2, 2023 09:00AM
Nov 2, 2023 07:00AM
Oct 27, 2023 07:00AM
Sep 18, 2023 07:01AM
Sep 18, 2023 07:00AM
Aug 3, 2023 07:00AM
Jun 22, 2023 08:30AM Kymera Therapeutics Receives FDA Orphan Drug Designation for KT-253, a Novel, Highly Potent and Selective MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
May 4, 2023 07:00AM
Feb 23, 2023 07:00AM
Feb 23, 2023 07:00AM
Jan 10, 2023 07:07AM
Jan 10, 2023 07:00AM
Jan 10, 2023 07:00AM
Dec 14, 2022 07:24AM Kymera Therapeutics (KYMR) Announces Positive Results from Phase 1 Clinical Trial Evaluating KT-474 in Patients with HS and AD and Sanofi's Decision to Advance KT-474 into Phase 2 Clinical Trials
Dec 14, 2022 07:00AM
Dec 14, 2022 07:00AM
Nov 3, 2022 07:05AM
Nov 3, 2022 07:05AM
Sep 15, 2022 07:30AM
Sep 15, 2022 07:30AM
Aug 11, 2022 10:01AM ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox
Aug 9, 2022 07:00AM
Jun 15, 2022 07:01AM
Jun 15, 2022 07:00AM
Jun 1, 2022 08:43AM
Jun 1, 2022 08:42AM
May 3, 2022 07:00AM
May 3, 2022 07:00AM Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
Feb 24, 2022 07:00AM
Feb 24, 2022 07:00AM
Nov 30, 2021 08:02AM
Nov 30, 2021 08:00AM
Nov 30, 2021 08:00AM
Nov 10, 2021 07:00AM
Nov 10, 2021 07:00AM Kymera Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Business Update
Aug 6, 2021 07:00AM

323,147 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All